Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bone morphogenetic protein 6 induces downregulation of pentraxin 3 expression in human granulosa lutein cells in women with polycystic ovary syndrome. | J Assist Reprod Genet | 2024 | 37930517 | PubTator, text mining | PubMed |
| The splendor and the tyranny of JAK inhibition. | Haematologica | 2024 | 37822272 | PubTator, text mining | PubMed |
| SORC: an integrated spatial omics resource in cancer. | Nucleic Acids Res | 2024 | 37811897 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of the Genetic and Epigenetic Alterations of Bone Morphogenetic Protein Receptors in Metastatic Breast Cancer. | Biochem Genet | 2024 | 37486509 | PubTator, text mining | PubMed |
| The pontine diffuse midline glioma, EGFR-subtype with ependymal features: Yet another face of diffuse midline glioma, H3K27-altered. | Brain Pathol | 2024 | 37331375 | PubTator, text mining | PubMed |
| Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib. | Haematologica | 2024 | 37259556 | PubTator, text mining | PubMed |
| Fibrodysplasia Ossificans Progressiva: A Case Report with Pseudo-Ankylosis of the Temporomandibular Joint. | Cleft Palate Craniofac J | 2024 | 36536588 | PubTator, text mining | PubMed |
| Fibrodysplasia Ossificans Progressiva Mimics Generalized Dystonia Disorder: A Case Report. | Cureus | 2023 | 38269236 | PubTator, text mining | PubMed |
| The Role of miRNAs in Childhood Acute Lymphoblastic Leukemia Relapse and the Associated Molecular Mechanisms. | Int J Mol Sci | 2023 | 38203290 | PubTator, text mining | PubMed |
| ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis. | Cancers (Basel) | 2023 | 38201581 | PubTator, text mining | PubMed |
| Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic Frontiers. | Genes (Basel) | 2023 | 38136984 | PubTator, text mining | PubMed |
| Palovarotene Action Against Heterotopic Ossification Includes a Reduction of Local Participating Activin A-Expressing Cell Populations. | JBMR Plus | 2023 | 38130748 | PubTator, text mining | PubMed |
| Retracted: LncXIST Facilitates Iron Overload and Iron Overload-Induced Islet Beta Cell Injury in Type 2 Diabetes through miR-130a-3p/ALK2 Axis. | Comput Intell Neurosci | 2023 | 38124847 | PubTator, text mining | PubMed |
| Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rate. | Commun Biol | 2023 | 38110614 | PubTator, text mining | PubMed |
| Transcriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension. | Sci Rep | 2023 | 38110438 | PubTator, text mining | PubMed |
| The Role of Circular RNAs in Male Infertility and Reproductive Cancers: A Narrative Review. | Iran J Med Sci | 2023 | 38094281 | PubTator, text mining | PubMed |
| Discovery of ginisortamab, a potent and novel anti-gremlin-1 antibody in clinical development for the treatment of cancer. | MAbs | 2023 | 38084840 | PubTator, text mining | PubMed |
| SMAD4 variants and its genotype-phenotype correlations to juvenile polyposis syndrome. | Hered Cancer Clin Pract | 2023 | 38066625 | PubTator, text mining | PubMed |
| A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation. | Acta Neuropathol | 2023 | 38066305 | PubTator, text mining | PubMed |
| The function and mechanism of PSMD14 in promoting progression and resistance to anlotinib in osteosarcoma. | Cancer Cell Int | 2023 | 38053170 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=10